Optimization of Medicinal Treatment of Patients with Glaucoma in Combination with Concurrent System Pathology. Part 1: Cardiovascular Pathology
This paper presents clinical and pharmacological drug interactions for the treatment of patients with glaucoma combined with concurrent cardiovascular pathology, risks of side effects, and adverse drug reactions. The article discusses the multifactor nature of glaucoma, age factors, and the directio...
Main Authors: | A. N. Zhuravleva, M. V. Zueva, E. B. Shustov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2020-09-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1270 |
Similar Items
-
Sustainable treatment of glaucoma patients with cardiovascular diseases
by: L. V. Yakubova, et al.
Published: (2020-09-01) -
Fractal Phototherapy in Neuroprotection of Glaucoma
by: M. V. Zueva, et al.
Published: (2019-10-01) -
Levels of cytokines in the aqueous humor of eyes with primary open angle glaucoma, pseudoexfoliation glaucoma and cataract
by: Nervana Khalef, et al.
Published: (2017-02-01) -
Glutathione s-transferase M1 and T1 genetic polymorphisms in Iranian patients with glaucoma
by: Fatemeh Kazemi Safa, et al.
Published: (2014-05-01) -
Pattern Electroretinography in Glaucoma Suspects and Early Primary Open Angle Glaucoma
by: Ebrahim Jafarzadehpour, et al.
Published: (2013-01-01)